tiprankstipranks
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market
RYTM
Rhythm Pharmaceuticals
RESEARCH TOOLSreports
Want to see RYTM full AI Analyst Report?

Rhythm Pharmaceuticals (RYTM) Stock News & Sentiment

608 Followers
RYTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RYTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
15h ago
RYTM
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
Premium
Company Announcements
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
1M ago
8K
RYTM
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
Premium
Company Announcements
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
1M ago
8K
RYTM
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
Premium
TipRanks Newswire
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
1M ago
PTN
RYTM
Rhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
Premium
Ratings
Rhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
2M ago
RYTM
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
Premium
Ratings
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
2M ago
RYTM
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
Premium
Ratings
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
2M ago
RYTM
More RYTM News >

RYTM News on the Web

Analysts’ Top Healthcare Picks: Corvus Pharmaceuticals (CRVS), Rhythm Pharmaceuticals (RYTM)
TipRanks News
Bullish
RA CAPITAL MANAGEMENT, L.P. Acquires Shares in Adicet Bio Inc
GuruFocus News
Neutral
PERCEPTIVE ADVISORS LLC Significantly Reduces Stake in Relay Therapeutics Inc
GuruFocus News
Neutral
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Vor Biopharma Inc
GuruFocus News
Neutral
Analysts Conflicted on These Healthcare Names: Rhythm Pharmaceuticals (RYTM) and Sarepta Therapeutics (SRPT)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Savara (SVRA) and Rhythm Pharmaceuticals (RYTM)
TipRanks News
Bullish
Rhythm Pharmaceuticals price target raised to $136 from $130 at RBC Capital
TipRanks News
Bullish
Rhythm Pharmaceuticals appoints Popovits to board of directors
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
RYTM
Sector Average
Media Buzz
This Week6 articles
Weekly Average13.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RYTM’s Media Buzz Sentiment?
6 articles about RYTM were published this week. In an average week, 13.75 articles are published.
    What is RYTM’s weekly average amount of articles?
    In an average week, 13.75 articles about RYTM are published.
      What is RYTM’s News Sentiment?
      100% of articles about RYTM were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week